SKP2 and prostate carcinoma: In the study, SKP2 modulated H3K4me3 levels by regulating TRAF6-mediated K63-linked ubiquitination of JARID1B, a key demethylase of H3K4me3, thereby influencing prostate cancer migration and recurrence (Lu et al., 2015).